Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized low molecular weight heparin for outpatient Covid-19
IRCT20231008059655N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of low molecular weight heparin calcium in coronavirus disease 2019 (COVID-19), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20231008059655N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231008059655N1.